SANGANI2025-10-012026-03-31SANGANI2026-03-31SANGANI2025-03-31SANGANI2025-04-012026-03-31SANGANI2025-10-012026-03-31in-capmkt:OtherExpenses1MemberSANGANI2025-04-012026-03-31in-capmkt:OtherExpenses1MemberSANGANI2026-03-31OtherCurrentLiabilitiesDomain1SANGANI2026-03-31OtherCurrentAssetsDomain1SANGANI2025-10-012026-03-31AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares000000SANGANINOTLISTEDINE0OVI01010SANGANI HOSPITALS LIMITEDSMEEquity2025-04-012026-03-312026-05-302026-05-25INRLakhsHalf YearlyYearlySingle segmentHEALTHCARE2026-05-3013:30:002026-05-3015:30:00trueCash Flow IndirectDeclaration of unmodified opinion2025-10-012026-03-31AuditedConsolidated86485600038100008686660006245740000-3151000383350002870006497000138415000804957000637090000637090000637090001523600032860001852200045187000000451870000-2530100019886000137770000101.441.440.00042.45272.2267Notes: <br /> 1.The above results were reviewed and recommended by the Audit Committee, at its meeting held on May 30,2025, for approval by the Board and these results were approved and taken on record at the meeting of the Board of Directors of the Company held on that date. The above result is subjected to Limited Review by the Statutory Auditors of the Company, as required under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. <br /> 2. These results have been prepared in accordance with the recognition and measurement principles laid down in AS-25 "Interim Financials Reporting" presribed under Section 133 of the Companies Act, 2013 read with the relevant Rules issued thereunder and other accounting principles generally accepted in India. <br /> 3. The figures for the half year ended on 31st March, 2026 are the balancing figures between the audited figures in respect of the full financial year 2025-26 and the half year ended unaudited figures upto 30th September, 2025. <br /> 4. The Company is engaged in the business of healthcare related services. In the management opinion, this is the only segment and hence there are no separate reportable segment as per AS-17 on Segement Reporting. <br /> 5. The Compnay has completed its Initial Public Offering ("IPO") of 37,92,000 new Equity Shares of Rs. 10 each at premium of Rs. 30 each per Equity Shares aggregating to Rs. 1516.80 lakhs. Pursuant to the IPO, the Equity Shares of the Company have got listed on NSE Emerge Platform on August 17, 2023. <br /> 6. During the year ended 31 March 2026, the Company has made investment aggregating to Rs. 18,81,11,970 in Sadbhavna Hospital and Medical Research Centre Private Limited. Pursuant to such investment, the Company holds 55% of the paid-up equity share capital of Sadbhavna Hospital and Medical Research Centre Private Limited as on 31 March 2026. Accordingly, Sadbhavna Hospital and Medical Research Centre Private Limited has become a Subsidiary Company of the Company within the meaning of Section 2(87) of the Companies Act, 2013 during the year. For the purpose of preparation of the Consolidated Financial Results, the financial statements of Sadbhavna Hospital and Medical Research Centre Private Limited have been consolidated with those of the Company in accordance with Accounting Standard (AS) 21 – “Consolidated Financial Statements”. The investment in the said Subsidiary Company is carried at cost in the Standalone Financial Statements of the Company in accordance with Accounting Standard (AS) 13 – “Accounting for Investments”, as Indian Accounting Standards (Ind AS) are not applicable to the Company. <br /> <br /> <br /> 7. The above consolidated financial result include the result of Subsidiary firm; M/s. Ankur Distributors and Subsidiary Company - Sadbhavna Hospital and Medical Research Centre Private Limited. <br /> 8. The above financial results are available on the website of the company i.e. www.sanganihospitals.com and on the website of emerge platform of National Stock Exchange i.e. www.nseindia.com <br /> 9. Figures for previous half year/ year have been regrouped wherever necessary to make them comparable. <br /> 2025-04-012026-03-31AuditedConsolidated1069581000596900010755500007556840000-2437000588390002870009872000176632000998877000766730000766730000766730001806300033590002142200055251000000552510000-25355000298960001377700001002.172.170.00043.02122.6777The Debt Service Coverage Ratio and Interest Service Coverage Ratio have increased significantly during the year primarily due to consolidation of financials consequent to acquisition of 55% stake in subsidiary company during the year.The Debt Service Coverage Ratio and Interest Service Coverage Ratio have increased significantly during the year primarily due to consolidation of financials consequent to acquisition of 55% stake in subsidiary company during the year.The Debt Service Coverage Ratio and Interest Service Coverage Ratio have increased significantly during the year primarily due to consolidation of financials consequent to acquisition of 55% stake in subsidiary company during the year.Other Expenses138415000Other Expenses176632000137770000272072000040984200000958190001275000080750000105300021878000500000091300054532100054623400040280000173660006088800001136419000227170000088777000020090000317956000500000000314000323270000400000001368900061546700075410001108480000256040008131490001136419000other current liabilities40280000Other Current Assets2560400028700098720000000000010159000-2437000-585984000-154340005360600002717300016615000-24007000-1384800062825000000180630000447620000044762000056981000000000050107000000000000-450000000-15208800000-1520880000004404600000000440460000044046000-632800000-63280000181670000118390000AuditedtrueR G G R & ASSOCIATEStrue2028-01-31